Uro-MP

Product NDC
58657-456
11-digit product format
586570456
Labeler code
58657
Product ID
58657-456_424f9d47-191c-f1c0-e063-6294a90ab63c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Methenamine, Sodium Phosphate, Monobasic, Anhydrous, Phenyl Salicylate, Methylene Blue and Hyoscyamine Sulfate
Dosage form
CAPSULE
Route
ORAL
Labeler
Method Pharmaceuticals, LLC
Marketing category
UNAPPROVED DRUG OTHER
Marketing start
2014-12-01
Substance
HYOSCYAMINE SULFATE; METHENAMINE; METHYLENE BLUE; PHENYL SALICYLATE; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Active strength
.12; 118; 10; 36; 40.8 mg/1; mg/1; mg/1; mg/1; mg/1
Pharmacologic classes
Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Oxidation-Reduction Activity [MoA], Oxidation-Reduction Agent [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Uro-MP
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
HYOSCYAMINE SULFATE.12 mg/1
METHENAMINE118 mg/1
METHYLENE BLUE10 mg/1
PHENYL SALICYLATE36 mg/1
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS40.8 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiF2R8V82B84, J50OIX95QV, T42P99266K, 28A37T47QO, KH7I04HPUU
Rxcui1087365

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
260b0da6-d3d7-262f-a60f-d4b36d5f1b4dProduct name620251210
c39b72c3-7732-4ed2-a995-e6aa3a665a54Product name320250819
95250459-30e4-45c1-b08a-993044f49109Product name220250805
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
a21a21e5-f36d-4c1f-8918-def921b8f7e3Product name320250124
fb7ab793-2c12-4079-b100-a64f73bef25aProduct name420240712
b0cbf770-6cc3-4aa4-9158-755110c2b9f7Product name220230717
dc7c5daa-021f-40dd-b00d-63982cb2067aProduct name120230426
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
f1e0dc7e-7d61-4625-b6d9-4894927679d7Product name220211025
9badc7be-250a-44ab-aa36-926af3f02679Product name120210527
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name520200925
e4870509-7e28-6f92-f0be-dd3dd889a9cfProduct name520200810
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cdProduct name220190619
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
816b97af-edc5-4060-aff1-b814bdbcad50Product name120190415
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
419aab54-5d5a-4146-9453-026d4a9991beProduct name220170525
26acd337-b838-40ac-bcbc-05c3b81c8712Product name120170323
08ffbcbf-26df-b99c-1dab-64fc4cfae89fProduct name220160823
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
89dac932-b90a-4410-9ab1-84c53e57de25Product name120150316
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508
5668b646-cd56-c3c7-bdea-3f6b1a8840dbProduct name120140508
597b1cfd-7b31-5048-62be-ca5cd740da2fProduct name120140508
684ea482-2e8b-14af-5664-b98f1e402036Product name120140508
810ab97e-f109-f41c-7c83-6a652a9cbf43Product name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2ddProduct name120140508
b060cc1a-fe47-856b-0b77-4448b5963de8Product name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
58657-456-012020-02-11C16284748780-19d75b9d0-421f-f424-e053-dadaa90a57ceURO-MP Capsules
58657-456-012020-02-11C16284748780-19d75b9d0-421f-f424-e053-dadaa90a57ceURO-MP Capsules
58657-456-012020-01-31C16284748780-19d75b9d0-421f-f424-e053-dadaa90a57ceURO-MP Capsules
58657-456-012020-01-31C16284748780-19d75b9d0-421f-f424-e053-dadaa90a57ceURO-MP Capsules

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
58657-456-01Uro-MP100 in 1 BOTTLECAPSULE10015

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
58657-456-01EA - Each58657-4563f524089-9b98-4d39-9f4c-ca02d9f3184812015-01-05

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
HYOSCYAMINE SULFATEACTIVE INGREDIENTF2R8V82B84URO-MP (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE) CAPSULE [METHOD PHARMACEUTICALS, LLC]4
METHENAMINEACTIVE INGREDIENTJ50OIX95QVURO-MP (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE) CAPSULE [METHOD PHARMACEUTICALS, LLC]4
METHYLENE BLUEACTIVE INGREDIENTT42P99266KURO-MP (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE) CAPSULE [METHOD PHARMACEUTICALS, LLC]4
PHENYL SALICYLATEACTIVE INGREDIENT28A37T47QOURO-MP (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE) CAPSULE [METHOD PHARMACEUTICALS, LLC]4
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUSACTIVE INGREDIENTKH7I04HPUUURO-MP (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE) CAPSULE [METHOD PHARMACEUTICALS, LLC]4
HYOSCYAMINEACTIVE MOIETYPX44XO846XURO-MP (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE) CAPSULE [METHOD PHARMACEUTICALS, LLC]4
METHENAMINEACTIVE MOIETYJ50OIX95QVURO-MP (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE) CAPSULE [METHOD PHARMACEUTICALS, LLC]4
METHYLENE BLUE CATIONACTIVE MOIETYZMZ79891ZHURO-MP (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE) CAPSULE [METHOD PHARMACEUTICALS, LLC]4
PHENYL SALICYLATEACTIVE MOIETY28A37T47QOURO-MP (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE) CAPSULE [METHOD PHARMACEUTICALS, LLC]4
SODIUM CATIONACTIVE MOIETYLYR4M0NH37URO-MP (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE) CAPSULE [METHOD PHARMACEUTICALS, LLC]4
CROSPOVIDONE (15 MPA.S AT 5%)INACTIVE INGREDIENT68401960MKURO-MP (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE) CAPSULE [METHOD PHARMACEUTICALS, LLC]4
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDURO-MP (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE) CAPSULE [METHOD PHARMACEUTICALS, LLC]4
FD&C RED NO. 3INACTIVE INGREDIENTPN2ZH5LOQYURO-MP (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE) CAPSULE [METHOD PHARMACEUTICALS, LLC]4
GELATININACTIVE INGREDIENT2G86QN327LURO-MP (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE) CAPSULE [METHOD PHARMACEUTICALS, LLC]4
LACTOSE, UNSPECIFIED FORMINACTIVE INGREDIENTJ2B2A4N98GURO-MP (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE) CAPSULE [METHOD PHARMACEUTICALS, LLC]4
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30URO-MP (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE) CAPSULE [METHOD PHARMACEUTICALS, LLC]4
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1AURO-MP (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE) CAPSULE [METHOD PHARMACEUTICALS, LLC]4
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4URO-MP (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE) CAPSULE [METHOD PHARMACEUTICALS, LLC]4
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPURO-MP (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE) CAPSULE [METHOD PHARMACEUTICALS, LLC]4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
58657-456URO-MP (METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS, PHENYL SALICYLATE, METHYLENE BLUE AND HYOSCYAMINE SULFATE) CAPSULE [METHOD PHARMACEUTICALS, LLC]14Current NDC, Legacy NDC, 1 package rows20241126_1e1b0dee-1a3b-4846-a212-c9febb3fc17d.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1087365methenamine 118 MG / sodium phosphate, monobasic 40.8 MG / phenyl salicylate 36 MG / methylene blue 10 MG / hyoscyamine sulfate 0.12 MG Oral CapsulePSN1e1b0dee-1a3b-4846-a212-c9febb3fc17d15
1087365hyoscyamine sulfate 0.12 MG / methenamine 118 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral CapsuleSCD1e1b0dee-1a3b-4846-a212-c9febb3fc17d15
1087365methenamine 118 MG / sodium phosphate, monobasic 40.8 MG / phenyl salicylate 36 MG / methylene blue 10 MG / hyoscyamine sulfate 0.12 MG Oral CapsulePSN6cbea1e3-1fc7-ac12-e053-2991aa0aabbe1
1087365hyoscyamine sulfate 0.12 MG / methenamine 118 MG / methylene blue 10 MG / phenyl salicylate 36 MG / sodium phosphate, monobasic 40.8 MG Oral CapsuleSCD6cbea1e3-1fc7-ac12-e053-2991aa0aabbe1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
58657-456-0158657045601100 CAPSULE in 1 BOTTLE (58657-456-01) 100 capsule2014-12-010000-00-00NoNoCurrent